Nostopharma provides treatment for orthopedic patients.
Nostopharma has raised $250K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2025.
Nostopharma's investors include National Science Foundation, TEDCO.
Nostopharma is headquartered in Bethesda, United States.
Nostopharma provides treatment for orthopedic patients.
Nostopharma is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nostopharma — Funding & Investors." VCBacked, January 23, 2025, https://www.vcbacked.co/company/nostopharma. Accessed September 29, 2026.
VCBacked. (2025). Nostopharma — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/nostopharma
{{cite web |title=Nostopharma — Funding & Investors |url=https://www.vcbacked.co/company/nostopharma |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated